Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 18.88 USD -3.67% Market Closed
Market Cap: 337.4m USD

Relative Value

The Relative Value of one RIGL stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.88 USD, Rigel Pharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RIGL Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
78
Median 3Y
3.1
Median 5Y
21.6
Industry
7.5
Forward
1.6
vs History
11
vs Industry
8
Median 3Y
-14.3
Median 5Y
-50.9
Industry
23.6
Forward
16
vs History
28
vs Industry
13
Median 3Y
-28.8
Median 5Y
-30.8
Industry
20.2
vs History
25
vs Industry
11
Median 3Y
-24.2
Median 5Y
-38
Industry
22.9
vs History
46
vs Industry
0
Median 3Y
-19.7
Median 5Y
18
Industry
2.8
vs History
88
vs Industry
69
Median 3Y
3.1
Median 5Y
21.5
Industry
7.7
Forward
1.5
vs History
87
vs Industry
70
Median 3Y
3.4
Median 5Y
21.8
Industry
9.6
vs History
11
vs Industry
10
Median 3Y
-21.4
Median 5Y
-55.6
Industry
4.9
Forward
10.6
vs History
11
vs Industry
9
Median 3Y
-17.6
Median 5Y
-54.6
Industry
4.9
Forward
10.4
vs History
30
vs Industry
13
Median 3Y
-28.2
Median 5Y
-29.9
Industry
5.4
vs History
20
vs Industry
10
Median 3Y
-24.5
Median 5Y
-33.8
Industry
4
vs History
87
vs Industry
35
Median 3Y
6.5
Median 5Y
43.1
Industry
5.1

Multiples Across Competitors

RIGL Competitors Multiples
Rigel Pharmaceuticals Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
337.3m USD 1.7 9.1 6.6 6.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 932 910.7 -161 278.1 -195 843 -193 608.2
US
Abbvie Inc
NYSE:ABBV
339.9B USD 5.9 81.8 15.5 23
US
Amgen Inc
NASDAQ:AMGN
158.8B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.5B USD 4.8 22.9 10 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.5B USD 10.9 -121.8 25.9 27.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.1 -529.8 -576.9 -561.5
AU
CSL Ltd
ASX:CSL
117.4B AUD 5.1 28.1 17.3 21.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.4B USD 4.4 13.7 12.2 13.7
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41B USD 17.5 -152.2 -682.1 -341.8
P/E Multiple
Earnings Growth PEG
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Average P/E: 30.4
9.1
55%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 278.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.9
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -121.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.8 N/A N/A
AU
CSL Ltd
ASX:CSL
28.1
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -152.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Average EV/EBITDA: 14.6
6.6
62%
0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 843 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -682.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Average EV/EBIT: 18.6
6.9
43%
0.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 608.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.2
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.7
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -341.8 N/A N/A